...
首页> 外文期刊>Progress in Artificial Intelligence >Spinal parenchymal occupation by neural stem cells after subpial delivery in adult immunodeficient rats
【24h】

Spinal parenchymal occupation by neural stem cells after subpial delivery in adult immunodeficient rats

机译:在成人免疫缺陷大鼠蛋白递送后神经干细胞脊柱实质职业

获取原文
获取原文并翻译 | 示例
           

摘要

Neural precursor cells (NSCs) hold great potential to treat a variety of neurodegenerative diseases and injuries to the spinal cord. However, current delivery techniques require an invasive approach in which an injection needle is advanced into the spinal parenchyma to deliver cells of interest. As such, this approach is associated with an inherent risk of spinal injury, as well as a limited delivery of cells into multiple spinal segments. Here, we characterize the use of a novel cell delivery technique that employs single bolus cell injections into the spinal subpial space. In immunodeficient rats, two subpial injections of human NSCs were performed in the cervical and lumbar spinal cord, respectively. The survival, distribution, and phenotype of transplanted cells were assessed 6-8 months after injection. Immunofluorescence staining and mRNA sequencing analysis demonstrated a near-complete occupation of the spinal cord by injected cells, in which transplanted human NSCs (hNSCs) preferentially acquired glial phenotypes, expressing oligodendrocyte (Olig2, APC) or astrocyte (GFAP) markers. In the outermost layer of the spinal cord, injected hNSCs differentiated into glia limitans-forming astrocytes and expressed human-specific superoxide dismutase and laminin. All animals showed normal neurological function for the duration of the analysis. These data show that the subpial cell delivery technique is highly effective in populating the entire spinal cord with injected NSCs, and has a potential for clinical use in cell replacement therapies for the treatment of ALS, multiple sclerosis, or spinal cord injury. Stem Cells Translational Medicine 2019
机译:神经前体细胞(NSCs)具有巨大的潜力,可治疗各种神经变性疾病和脊髓损伤。然而,当前的递送技术需要一种侵入性的方法,其中注射针头进入脊柱实质以传递感兴趣的细胞。因此,这种方法与脊柱损伤的固有风险相关,以及将细胞的有限递送到多个脊段中。这里,我们表征了使用单个推注电池注入的新细胞输送技术进入脊类空间。在免疫缺陷大鼠中,分别在宫颈和腰椎脊髓中进行两种人NSCs的子进样。注射后6-8个月评估移植细胞的存活率,分布和表型。免疫荧光染色和mRNA测序分析证明了通过注射细胞对脊髓的接近完全占用,其中移植的人NSCs(HNSCs)优先获得胶质表型,表达寡核细胞(OLIG2,APC)或半织物(GFAP)标记。在脊髓的最外层中,注射HNSCs分化为Glia限幅体形成星形胶质细胞并表达人特异性超氧化物歧化酶和层粘连蛋白。所有动物均显示正常的神经功能,以便在分析的持续时间内。这些数据表明,子级电池输送技术在填充整个脊髓与注射的NSCs填充整个脊髓,并且具有用于治疗ALS,多发性硬化或脊髓损伤的细胞替代疗法的临床应用。 2019年干细胞翻译医学

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号